Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-29 Purchase |
2022-07-01 4:05 pm |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
20,000 | $1.71 | $34,200 | 27,754 (Indirect Direct) |
View |
2022-03-25 Purchase |
2022-03-28 08:00 am |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
100,000 | $0.245 | $24,500 | 248,024 (Indirect Direct) |
View |
2021-09-28 Purchase |
2021-09-28 5:04 pm |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
12,000 | $0.61 | $7,320 | 148,024 (Indirect Direct) |
View |
2021-03-24 Purchase |
2021-03-25 07:00 am |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
16,733 | $1.32 | $22,088 | 136,024 (Indirect Direct) |
View |
2020-12-30 Purchase |
2021-01-04 5:01 pm |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
35,000 | $0.68 | $23,800 | 119,291 (Indirect Direct) |
View |
2020-08-13 Purchase |
2020-08-17 09:03 am |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
60,000 | $0.91 | $54,600 | 84,291 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-05 Other |
2025-02-27 6:48 pm |
N/A N/A |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
0 | $3.3 | 247,934 (Indirect) |
View |
2025-02-05 Other |
2025-02-27 6:48 pm |
N/A N/A |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
5 | $3.38 | 247,934 (Direct) |
View |
2025-02-05 Other |
2025-02-27 6:48 pm |
N/A N/A |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
1 | $0.15 | 247,934 (Indirect) |
View |
2025-02-25 Option Award |
2025-02-27 6:48 pm |
2026-02-25 2035-02-25 |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
247,916 | $0 | 247,934 (Direct) |
View |
2024-02-27 Option Award(A) |
2024-03-06 5:01 pm |
2025-02-27 2034-02-27 |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
3,448,911 | $0 | 3,448,911 (Direct) |
View |
2024-02-27 Option Award |
2024-02-29 5:08 pm |
2025-02-27 2034-02-27 |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
3,448,911 | $0 | 3,448,911 (Direct) |
View |
2023-02-23 Option Award |
2023-02-24 6:34 pm |
2024-02-23 2033-02-23 |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
1,400,000 | $0 | 1,400,000 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 5:17 pm |
2023-02-15 2032-02-15 |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
20,000,000 | $0 | 20,000,000 (Direct) |
View |
2021-02-23 Option Award |
2021-02-25 5:54 pm |
2022-02-23 2031-02-23 |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
6,000,000 | $0 | 6,000,000 (Direct) |
View |
2020-05-04 Option Award |
2020-05-06 6:22 pm |
2021-05-04 2030-05-04 |
Tonix Pharmaceuticals Holding Corp. | TNXP | LEDERMAN SETH Chief Executive Officer |
4,000,000 | $0 | 4,000,000 (Direct) |
View |